title: [Diagnosis and therapy of uterine sarcoma].
abstract: Radical surgery in stage I and II uterine sarcoma removing all tumor manifestations is the only curative therapy option for early stage disease. Larger tumors (> 4 cm) and the presence of lymph node metastasis correlate with a high local recurrence rate. For these tumors adjuvant radiation and/or adjuvant chemotherapy may be recommended after surgical therapy. Adjuvant therapy however, should preferably be considered for uterine stromal sarcomas and mixed mesodermal tumors. The toxicity of radiation and/or chemotherapy is greater than any possible benefit for patients with leiomysarcomas as these tumors rarely respond to radiation or chemotherapy. For advanced (> stage I and II) and recurrent disease, curative therapy options are not available and palliative therapy for these patients has to take into consideration the negative side effects and weigh up quality of life against an often very limited possible benefit of such therapy.
authors.affiliation: Klinik für Gynäkologie und Geburtshilfe, Georg-August-Universität Göttingen. viereck@med.uni-goettingen.de
authors.forename: V
authors.initials: V
authors.lastname: Viereck
authors.forename: A
authors.initials: A
authors.lastname: Huschmand Nia
authors.forename: H U
authors.initials: HU
authors.lastname: Pauer
authors.forename: G
authors.initials: G
authors.lastname: Emons
authors.forename: T
authors.initials: T
authors.lastname: Krauss
mesh_terms: D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D012509:Sarcoma / Q000145:classification / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D014594:Uterine Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy